MedPath

Efficacy of emollient, anti-inflammatory cream contining Isoleucine vs. standard emollient cream in children with facial atopic dermatitis

Conditions
Atopic dermatitis of the face in children
Registration Number
NL-OMON21723
Lead Sponsor
Investigator Sponsor TrialProf GL MarsegliaPediatric Clinic Ospdale San Matteo
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Children aged 1-12 years

Atopic Dermatitis mild to moderate

Exclusion Criteria

Severe AD

Treatment with systemic anti-inflammatory drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EASI score (eczema, itch, infiltration,escoriation)<br />
Secondary Outcome Measures
NameTimeMethod
Investigator global assessement<br />
© Copyright 2025. All Rights Reserved by MedPath